/AI%20(artificial%20intelligence)/AI%20technology%20-%20by%20Wanan%20Yossingkum%20via%20iStock.jpg)
The healthcare industry is on the cusp of a transformation powered by artificial intelligence’s (AI) ability to deliver personalized care, optimize diagnoses, and accelerate drug discovery. A recent survey shows that 90% of healthcare executives are seeing positive return on investment (ROI) from generative AI investments - proof that AI is becoming critical for long-term growth.
Few investors grasp this revolution as clearly as Cathie Wood, the visionary behind Ark Invest. Known for backing disruptive innovation, Wood’s latest move has been a pivot toward Tempus AI, Inc (TEM), a rising player in AI-driven precision medicine.